Lupin Q2 net profit seen up 35% at Rs 377 cr

MUMBAI: Pharmaceutical major Lupin is expected to report 35 per cent rise in net profit for September 2013 quarter, says ET Now poll. According to the poll, the company is likely to report a net profit of Rs 377 crore for the quarter against a net profit of Rs 280 crore in the corresponding quarter last fiscal.

Net sales are seen growing 19 per cent to Rs 2650 crore from Rs 2219 crore in year-ago period.

EBITDA is seen at Rs 627 crore, up 37 per cent against Rs 457 crore while margins are seen at 23.7 per cent vs 20.6 per cent.

According to analysts, the company’s US business is seen growing around 30 per cent while domestic business may see a growth of 10 – 12 per cent.

Revenues growth is seen on ramp up of sale of Tricor and favourable currency. Limited competition products are also likely to aid revenues.

Earnings from Japanese markets are likely to remain flat on rupee depreciation.